Read end-to-end by a FundingAtlas editor against the official source.
Quick answer
British Patient Capital Co-Investment is a UK funding programme. UK high-growth companies raising late-stage rounds via BPC fund and direct co-investments. Funding: £10m+ co-invest. UK scaleups raising Series B+ patient capital. It is published as a standard listing — verify current rounds and full criteria on the official source before applying.
Funding amount
£10m+ co-invest
Region
United Kingdom
Stage
Growth
Provider
British Business Bank — British Patient Capital
Advisor view
This programme is an investor-side route — the rules govern your investors as much as your business. Treat it as a structuring decision, not a fundraising trick. Get advance assurance or the equivalent confirmation before issuing shares, and brief your investors and their accountants in writing. A clean cap table and matching share register are worth more than a polished pitch.
Frequently asked questions
- Who is British Patient Capital Co-Investment really for?
- It works best for organisations that already meet the eligibility test on paper and have the operational maturity to deliver — not for businesses hoping the application will force them to formalise.
- What are the most common reasons applications are rejected?
- Weak evidence, eligibility misses, and applications that read as business as usual rather than the specific intent of the scheme. Most rejections are avoidable with earlier preparation.
- Can early-stage startups apply?
- Sometimes — but the strongest applicants usually have at least minimum trading history, a defined plan and the team to deliver. If you are pre-revenue with no plan, expect to be too early.
- How competitive is it?
- Demand routinely outstrips supply for the high-profile UK programmes. Treat any competitive call as a serious bid that needs four to six weeks of preparation, not a weekend.
- What should I prepare before I apply?
- A short written summary of what you are doing and why it qualifies, your latest accounts or forecasts, and any partner or evidence the scheme expects. Get adviser sign-off before submission.
- What happens after a successful application?
- Expect monitoring, reporting and milestone evidence. Plan the reporting cadence and internal owner before the funding lands, not afterwards.
Who it's for
UK scaleups raising Series B+ patient capital.
Usually too early when
Advisor signal
You have no incorporated UK trading entity, no draft cap table, no defined funding round, or you have already issued the shares you want covered.
Eligibility
UK high-growth companies raising late-stage rounds via BPC fund and direct co-investments.
Common reasons applications fail
Issuing shares before getting advance assurance, breaching qualifying-trade rules, using the wrong share class, or falling foul of connected-persons rules.
What improves your odds
A tight one-page company summary, a clean cap table, and confirmation from an experienced accountant that you meet the qualifying-trade and gross-asset tests.
Typical successful applicant
A UK-incorporated company with a defined funding round, an experienced investor lead or fund manager, and an accountant familiar with HMRC advance assurance.
Common misconceptions
It is not free money — it is an investor relief or co-investment that makes your shares more attractive. It does not replace a fundable business model.
What comes next
After investment lands, file the compliance paperwork on time, keep your share register tidy, and plan the next round before runway gets thin.
Funding context
Sits alongside the rest of the UK equity stack — angel, EIS, SEIS, VCT, growth-stage funds and patient capital. The right combination depends on round size, investor base and time horizon.
Related routes
- Regional Funding vs National Funding
- Which funding pathway should I follow?
- Accelerated Knowledge Transfer (aKT)
- Enterprise Management Incentives (EMI)
- Future Fund: Breakthrough
- Growth Guarantee Scheme
- Innovate UK BridgeAI
- Innovate UK Collaborative R&D
- Innovation Loans Future Economy: Investor Partnerships
- Innovate UK Net Zero Living
- Northern Gritstone Investment Fund
- Innovation Funding Pathway
Industries
Objectives
Regions